• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A型单胺氧化酶调节神经退行性变和神经保护中神经元的生死。

Type A monoamine oxidase regulates life and death of neurons in neurodegeneration and neuroprotection.

机构信息

Department of Neurosciences, Gifu International Institute of Biotechnology, Kakamigahara, Gifu, Japan.

出版信息

Int Rev Neurobiol. 2011;100:85-106. doi: 10.1016/B978-0-12-386467-3.00005-4.

DOI:10.1016/B978-0-12-386467-3.00005-4
PMID:21971004
Abstract

In Parkinson's disease, type B monoamine oxidase (MAO-B) is proposed to play an important role in the pathogenesis through production of reactive oxygen species and neurotoxins from protoxicants, such as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. In addition, inhibitors of MAO-B protect neurons in the cellular and animal models of Parkinson's and Alzheimer's diseases. However, the role of type A MAO (MAO-A) in neuronal death and neuroprotection by MAO-B inhibitors has been scarcely elucidated. This chapter presents our recent results on the involvement of MAO-A in the activation of mitochondrial death signal pathway and in the induction of prosurvival genes to prevent cell death with MAO-B inhibitors. The roles of MAO-A in the regulation of neuronal survival and death are discussed in concern to find a novel strategy to protect neurons in age-associated neurodegenerative disorders and depression.

摘要

在帕金森病中,B 型单胺氧化酶(MAO-B)被认为通过产生活性氧物种和神经毒素(如 1-甲基-4-苯基-1,2,3,6-四氢吡啶)在发病机制中发挥重要作用。此外,MAO-B 抑制剂可保护帕金森病和阿尔茨海默病的细胞和动物模型中的神经元。然而,MAO-A 在 MAO-B 抑制剂诱导的神经元死亡和神经保护中的作用尚未得到充分阐明。本章介绍了我们最近关于 MAO-A 参与线粒体死亡信号通路激活以及诱导生存相关基因以防止 MAO-B 抑制剂诱导细胞死亡的研究结果。讨论了 MAO-A 在调节神经元存活和死亡中的作用,以期找到一种保护与年龄相关的神经退行性疾病和抑郁症相关神经元的新策略。

相似文献

1
Type A monoamine oxidase regulates life and death of neurons in neurodegeneration and neuroprotection.A型单胺氧化酶调节神经退行性变和神经保护中神经元的生死。
Int Rev Neurobiol. 2011;100:85-106. doi: 10.1016/B978-0-12-386467-3.00005-4.
2
Type A and B monoamine oxidase in age-related neurodegenerative disorders: their distinct roles in neuronal death and survival.与年龄相关的神经退行性疾病中的 A 型和 B 型单胺氧化酶:它们在神经元死亡和存活中的不同作用。
Curr Top Med Chem. 2012;12(20):2177-88. doi: 10.2174/156802612805219950.
3
Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases.新型双功能药物靶向单胺氧化酶抑制和铁螯合,作为帕金森病及其他神经退行性疾病神经保护的一种方法。
J Neural Transm (Vienna). 2004 Oct;111(10-11):1455-71. doi: 10.1007/s00702-004-0143-x. Epub 2004 Apr 20.
4
Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition.用于神经退行性疾病的新型多功能神经保护铁螯合剂 - 单胺氧化酶抑制剂药物:抗氧化活性、预防脂质过氧化物形成及单胺氧化酶抑制的体外研究
J Neurochem. 2005 Oct;95(1):68-78. doi: 10.1111/j.1471-4159.2005.03340.x.
5
Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease.B型单胺氧化酶抑制剂在帕金森病中的神经保护作用机制
Expert Rev Neurother. 2009 Aug;9(8):1233-50. doi: 10.1586/ern.09.68.
6
Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression.神经精神疾病中单胺氧化酶(MAO)表达的调节:A型MAO表达涉及的遗传和环境因素。
J Neural Transm (Vienna). 2016 Feb;123(2):91-106. doi: 10.1007/s00702-014-1362-4. Epub 2015 Jan 22.
7
Novel MAO-B inhibitors: potential therapeutic use of the selective MAO-B inhibitor PF9601N in Parkinson's disease.新型 MAO-B 抑制剂:选择性 MAO-B 抑制剂 PF9601N 在帕金森病中的潜在治疗用途。
Int Rev Neurobiol. 2011;100:217-36. doi: 10.1016/B978-0-12-386467-3.00011-X.
8
Anti-apoptotic effect of Mao-B inhibitor PF9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] is mediated by p53 pathway inhibition in MPP+-treated SH-SY5Y human dopaminergic cells.Mao-B 抑制剂 PF9601N[N-(2-丙炔基)-2-(5-苄氧基-吲哚基)甲胺]通过抑制 p53 通路发挥抗凋亡作用,在 MPP+-处理的 SH-SY5Y 人多巴胺能细胞中。
J Neurochem. 2008 Jun 1;105(6):2404-17. doi: 10.1111/j.1471-4159.2008.05326.x.
9
Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.单胺氧化酶-B抑制剂雷沙吉兰和铁螯合剂VK-28的双功能药物衍生物,作为治疗脑老化和老化神经退行性疾病的更有效方法。
Mech Ageing Dev. 2005 Feb;126(2):317-26. doi: 10.1016/j.mad.2004.08.023.
10
Neuroprotection by monoamine oxidase B inhibitors: a therapeutic strategy for Parkinson's disease?单胺氧化酶B抑制剂的神经保护作用:帕金森病的一种治疗策略?
Bioessays. 2004 Jan;26(1):80-90. doi: 10.1002/bies.10378.

引用本文的文献

1
Exploring the 1-(4-Nitrophenyl)-3-arylprop-2-en-1-one Scaffold for the Selective Inhibition of Monoamine Oxidase B.探索1-(4-硝基苯基)-3-芳基丙-2-烯-1-酮支架对单胺氧化酶B的选择性抑制作用。
ACS Med Chem Lett. 2024 Sep 27;15(10):1685-1691. doi: 10.1021/acsmedchemlett.4c00246. eCollection 2024 Oct 10.
2
Oxidation of Flavin by Molecular Oxygen: Computational Insights into a Possible Radical Mechanism.分子氧对黄素的氧化:关于可能的自由基机制的计算见解
ACS Omega. 2024 May 22;9(22):23431-23441. doi: 10.1021/acsomega.4c00307. eCollection 2024 Jun 4.
3
Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson's disease.
帕金森病中线粒体中单胺氧化酶、多巴胺、α-突触核蛋白与基因之间的毒性相互作用。
J Neural Transm (Vienna). 2024 Jun;131(6):639-661. doi: 10.1007/s00702-023-02730-6. Epub 2024 Jan 9.
4
"Click Chemistry": An Emerging Tool for Developing a New Class of Structural Motifs against Various Neurodegenerative Disorders.“点击化学”:开发针对各种神经退行性疾病的新型结构基序的新兴工具。
ACS Omega. 2023 Nov 14;8(47):44437-44457. doi: 10.1021/acsomega.3c04960. eCollection 2023 Nov 28.
5
Comparison of Monoamine Oxidase-A, Aβ Plaques, Tau, and Translocator Protein Levels in Postmortem Human Alzheimer's Disease Brain.阿尔茨海默病患者死后大脑中单胺氧化酶-A、Aβ 斑块、tau 蛋白和转位蛋白水平的比较。
Int J Mol Sci. 2023 Jun 28;24(13):10808. doi: 10.3390/ijms241310808.
6
Synthesis and Biological Evaluation of -Aminoalkyl-Hispidol Analogs as Multifunctional Monoamine Oxidase-B Inhibitors towards Management of Neurodegenerative Diseases.作为多功能单胺氧化酶 -B 抑制剂用于神经退行性疾病治疗的α-氨基烷基-漆姑醇类似物的合成与生物学评价
Antioxidants (Basel). 2023 Apr 29;12(5):1033. doi: 10.3390/antiox12051033.
7
NMN Alleviates NP-Induced Learning and Memory Impairment Through SIRT1 Pathway in PC-12 Cell.烟酰胺单核苷酸通过SIRT1通路减轻PC-12细胞中神经肽诱导的学习和记忆损伤。
Mol Neurobiol. 2023 May;60(5):2871-2883. doi: 10.1007/s12035-023-03251-9. Epub 2023 Feb 6.
8
Elevated Monoamine Oxidase-A in Anterior Cingulate of Post-Mortem Human Parkinson's Disease: A Potential Surrogate Biomarker for Lewy Bodies?人死后帕金森病患者前扣带回中单胺氧化酶-A 升高:路易体的潜在替代生物标志物?
Cells. 2022 Dec 10;11(24):4000. doi: 10.3390/cells11244000.
9
The Role of the Thioredoxin System in Brain Diseases.硫氧还蛋白系统在脑部疾病中的作用。
Antioxidants (Basel). 2022 Oct 31;11(11):2161. doi: 10.3390/antiox11112161.
10
Kinetics, mechanism, and inhibition of monoamine oxidase.单胺氧化酶的动力学、机制和抑制作用。
J Neural Transm (Vienna). 2018 Nov;125(11):1659-1683. doi: 10.1007/s00702-018-1861-9. Epub 2018 Mar 7.